Skip to main content

Ron Waksman, MD

Original Contribution
05/04/2009
ABSTRACT: Background. Recent data suggest a clinical benefit with the systematic use of thrombus aspiration (TA) for the treatment of ST-elevation myocardial infarction (STEMI). Nevertheless, the impact of TA as a treatment strategy for stent...
ABSTRACT: Background. Recent data suggest a clinical benefit with the systematic use of thrombus aspiration (TA) for the treatment of ST-elevation myocardial infarction (STEMI). Nevertheless, the impact of TA as a treatment strategy for stent...
ABSTRACT: Background. Recent...
05/04/2009
Journal of Invasive Cardiology
Original Contribution
09/05/2009
ABSTRACT: Background. Stents are used to treat the first and even successive episodes of in-stent restenosis (ISR). Methods. In 18 patients (19 lesions), intravascular ultrasound (IVUS) was performed after placement of a stent for a...
ABSTRACT: Background. Stents are used to treat the first and even successive episodes of in-stent restenosis (ISR). Methods. In 18 patients (19 lesions), intravascular ultrasound (IVUS) was performed after placement of a stent for a...
ABSTRACT: Background. Stents are...
09/05/2009
Journal of Invasive Cardiology
Feature
06/19/2008
How do registries differ from randomized controlled trials (RCTs)? Unlike RCTs, registries are not built on randomization and therefore may at times be subject to case selection. Furthermore, it is often difficult to draw a conclusion from...
How do registries differ from randomized controlled trials (RCTs)? Unlike RCTs, registries are not built on randomization and therefore may at times be subject to case selection. Furthermore, it is often difficult to draw a conclusion from...
How do registries differ from...
06/19/2008
Cath Lab Digest
Original Contribution
06/28/2011
ABSTRACT: Background. The process of in-stent neointimal hyperplasia (NIH) between drug-eluting stents (DES) and bare metal stents (BMS) might be different. We compared in vivo composition of in-stent NIH between DES and BMS using virtual...
ABSTRACT: Background. The process of in-stent neointimal hyperplasia (NIH) between drug-eluting stents (DES) and bare metal stents (BMS) might be different. We compared in vivo composition of in-stent NIH between DES and BMS using virtual...
ABSTRACT: Background. The...
06/28/2011
Journal of Invasive Cardiology
08/01/2008
Vessel closure is a major complication after percutaneous coronary intervention (PCI) and is associated with a high rate of adverse clinical events.1,2 The occurrence of abrupt closure has been observed and evaluated mostly after stent...
Vessel closure is a major complication after percutaneous coronary intervention (PCI) and is associated with a high rate of adverse clinical events.1,2 The occurrence of abrupt closure has been observed and evaluated mostly after stent...
Vessel closure is a major...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Vascular brachytherapy (VBT) has evolved as a viable method to treat in-stent restenosis (ISR), which is due to neointimal hyperplasia distributed either focally or diffusely over the entire length of the stent.1 Radiation acts by inhibiting...
Vascular brachytherapy (VBT) has evolved as a viable method to treat in-stent restenosis (ISR), which is due to neointimal hyperplasia distributed either focally or diffusely over the entire length of the stent.1 Radiation acts by inhibiting...
Vascular brachytherapy (VBT) has...
08/01/2008
Journal of Invasive Cardiology
Review
08/01/2008
Primary percutaneous coronary intervention (PCI) is established as optimal therapy for patients with ST-elevation myocardial infarction (STEMI).1 The goal of primary PCI is to achieve a thrombolysis in myocardial infarction (TIMI) 3 flow and...
Primary percutaneous coronary intervention (PCI) is established as optimal therapy for patients with ST-elevation myocardial infarction (STEMI).1 The goal of primary PCI is to achieve a thrombolysis in myocardial infarction (TIMI) 3 flow and...
Primary percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Aortic stenosis (AS) is prevalent in 2–7% of the population over 65 years of age.1 Atherosclerotic coronary artery disease (CAD) coexists in 27–43% of patients with AS.2 Management of CAD in patients with AS poses special problems since...
Aortic stenosis (AS) is prevalent in 2–7% of the population over 65 years of age.1 Atherosclerotic coronary artery disease (CAD) coexists in 27–43% of patients with AS.2 Management of CAD in patients with AS poses special problems since...
Aortic stenosis (AS) is...
08/01/2008
Journal of Invasive Cardiology
Case Report
02/12/2009
From the Department of Internal Medicine, Division of Cardiology, Washington Hospital Center, Washington, D.C. Disclosures: Dr. Waksman reports receiving speaker honoraria from Biotronik, Medtronic, and Boston Scientific, and has received...
From the Department of Internal Medicine, Division of Cardiology, Washington Hospital Center, Washington, D.C. Disclosures: Dr. Waksman reports receiving speaker honoraria from Biotronik, Medtronic, and Boston Scientific, and has received...
From the Department of Internal...
02/12/2009
Journal of Invasive Cardiology